Net Income (Loss) Attributable to Parent in USD of ABBOTT LABORATORIES from 2011 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
ABBOTT LABORATORIES quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from 2011 to Q3 2025.
  • ABBOTT LABORATORIES Net Income (Loss) Attributable to Parent for the quarter ending 30 Sep 2025 was $1.64B, a 0.12% decline year-over-year.
  • ABBOTT LABORATORIES Net Income (Loss) Attributable to Parent for the twelve months ending 30 Sep 2025 was $14B, a 142% increase year-over-year.
  • ABBOTT LABORATORIES annual Net Income (Loss) Attributable to Parent for 2024 was $13.4B, a 134% increase from 2023.
  • ABBOTT LABORATORIES annual Net Income (Loss) Attributable to Parent for 2023 was $5.72B, a 17.5% decline from 2022.
  • ABBOTT LABORATORIES annual Net Income (Loss) Attributable to Parent for 2022 was $6.93B, a 1.95% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

ABBOTT LABORATORIES Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $14B $1.64B -$2M -0.12% 01 Jul 2025 30 Sep 2025 10-Q 29 Oct 2025
Q2 2025 $14B $1.78B +$477M +36.6% 01 Apr 2025 30 Jun 2025 10-Q 30 Jul 2025
Q1 2025 $13.5B $1.33B +$100M +8.16% 01 Jan 2025 31 Mar 2025 10-Q 30 Apr 2025
Q4 2024 $13.4B $9.23B +$7.64B +479% 01 Oct 2024 31 Dec 2024 10-K 21 Feb 2025
Q3 2024 $5.77B $1.65B +$210M +14.6% 01 Jul 2024 30 Sep 2024 10-Q 29 Oct 2025
Q2 2024 $5.56B $1.3B -$73M -5.31% 01 Apr 2024 30 Jun 2024 10-Q 30 Jul 2025
Q1 2024 $5.63B $1.23B -$93M -7.06% 01 Jan 2024 31 Mar 2024 10-Q 30 Apr 2025
Q4 2023 $5.72B $1.59B +$561M +54.3% 01 Oct 2023 31 Dec 2023 10-K 21 Feb 2025
Q3 2023 $5.16B $1.44B +$1M +0.07% 01 Jul 2023 30 Sep 2023 10-Q 31 Oct 2024
Q2 2023 $5.16B $1.38B -$643M -31.9% 01 Apr 2023 30 Jun 2023 10-Q 31 Jul 2024
Q1 2023 $5.8B $1.32B -$1.13B -46.1% 01 Jan 2023 31 Mar 2023 10-Q 02 May 2024
Q4 2022 $6.93B $1.03B -$956M -48.1% 01 Oct 2022 31 Dec 2022 10-K 21 Feb 2025
Q3 2022 $7.89B $1.44B -$665M -31.7% 01 Jul 2022 30 Sep 2022 10-Q 01 Nov 2023
Q2 2022 $8.55B $2.02B +$829M +69.7% 01 Apr 2022 30 Jun 2022 10-Q 03 Aug 2023
Q1 2022 $7.73B $2.45B +$654M +36.5% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023
Q4 2021 $7.07B $1.99B -$173M -8% 01 Oct 2021 31 Dec 2021 10-K 16 Feb 2024
Q3 2021 $7.24B $2.1B +$868M +70.5% 01 Jul 2021 30 Sep 2021 10-Q 01 Nov 2022
Q2 2021 $6.38B $1.19B +$652M +121% 01 Apr 2021 30 Jun 2021 10-Q 02 Aug 2022
Q1 2021 $5.72B $1.79B +$1.23B +218% 01 Jan 2021 31 Mar 2021 10-Q 03 May 2022
Q4 2020 $4.5B $2.16B +$1.11B +106% 01 Oct 2020 31 Dec 2020 10-K 17 Feb 2023
Q3 2020 $3.38B $1.23B +$272M +28.3% 01 Jul 2020 30 Sep 2020 10-Q 03 Nov 2021
Q2 2020 $3.11B $537M -$469M -46.6% 01 Apr 2020 30 Jun 2020 10-Q 04 Aug 2021
Q1 2020 $3.58B $564M -$108M -16.1% 01 Jan 2020 31 Mar 2020 10-Q 05 May 2021
Q4 2019 $3.69B $1.05B +$395M +60.4% 01 Oct 2019 31 Dec 2019 10-K 21 Feb 2020
Q3 2019 $3.29B $960M +$397M +70.5% 01 Jul 2019 30 Sep 2019 10-Q 04 Nov 2020
Q2 2019 $2.9B $1.01B +$273M +37.2% 01 Apr 2019 30 Jun 2019 10-Q 29 Jul 2020
Q1 2019 $2.62B $672M +$254M +60.8% 01 Jan 2019 31 Mar 2019 10-Q 29 Apr 2020
Q4 2018 $2.37B $654M +$1.48B 01 Oct 2018 31 Dec 2018 10-K 21 Feb 2020
Q3 2018 $886M $563M -$40M -6.63% 01 Jul 2018 30 Sep 2018 10-K 21 Feb 2020
Q2 2018 $926M $733M +$450M +159% 01 Apr 2018 30 Jun 2018 10-K 21 Feb 2020
Q1 2018 $476M $418M -$1M -0.24% 01 Jan 2018 31 Mar 2018 10-K 21 Feb 2020
Q4 2017 $477M -$828M -$1.63B -204% 01 Oct 2017 31 Dec 2017 10-K 22 Feb 2019
Q3 2017 $2.1B $603M +$932M 01 Jul 2017 30 Sep 2017 10-K 22 Feb 2019
Q2 2017 $1.17B $283M -$332M -54% 01 Apr 2017 30 Jun 2017 10-K 22 Feb 2019
Q1 2017 $1.5B $419M +$103M +32.6% 01 Jan 2017 31 Mar 2017 10-K 22 Feb 2019
Q4 2016 $1.4B $798M +$31M +4.04% 01 Oct 2016 31 Dec 2016 10-K 16 Feb 2018
Q3 2016 $1.37B -$329M -$909M -157% 01 Jul 2016 30 Sep 2016 10-K 16 Feb 2018
Q2 2016 $2.28B $615M -$169M -21.6% 01 Apr 2016 30 Jun 2016 10-K 16 Feb 2018
Q1 2016 $2.45B $316M -$1.98B -86.2% 01 Jan 2016 31 Mar 2016 10-K 16 Feb 2018
Q4 2015 $4.42B $767M -$138M -15.2% 01 Oct 2015 31 Dec 2015 10-K 17 Feb 2017
Q3 2015 $4.56B $580M +$42M +7.81% 01 Jul 2015 30 Sep 2015 10-K 17 Feb 2017
Q2 2015 $4.52B $784M +$318M +68.2% 01 Apr 2015 30 Jun 2015 10-K 17 Feb 2017
Q1 2015 $4.2B $2.29B +$1.92B +511% 01 Jan 2015 31 Mar 2015 10-K 17 Feb 2017
Q4 2014 $2.28B $905M +$316M +53.7% 01 Oct 2014 31 Dec 2014 10-K 19 Feb 2016
Q3 2014 $1.97B $538M -$428M -44.3% 01 Jul 2014 30 Sep 2014 10-K 19 Feb 2016
Q2 2014 $2.4B $466M -$10M -2.1% 01 Apr 2014 30 Jun 2014 10-K 19 Feb 2016
Q1 2014 $2.41B $375M -$170M -31.2% 01 Jan 2014 31 Mar 2014 10-K 19 Feb 2016
Q4 2013 $2.58B $589M -$464M -44.1% 01 Oct 2013 31 Dec 2013 10-K 27 Feb 2015
Q3 2013 $3.04B $966M -$977M -50.3% 01 Jul 2013 30 Sep 2013 10-K 27 Feb 2015
Q2 2013 $4.02B $476M -$1.25B -72.4% 01 Apr 2013 30 Jun 2013 10-K 27 Feb 2015
Q1 2013 $5.27B $545M -$697M -56.1% 01 Jan 2013 31 Mar 2013 10-K 27 Feb 2015
Q4 2012 $5.96B $1.05B 01 Oct 2012 31 Dec 2012 10-K 21 Feb 2014
Q3 2012 $1.94B 01 Jul 2012 30 Sep 2012 10-K 21 Feb 2014
Q2 2012 $1.73B 01 Apr 2012 30 Jun 2012 10-K 21 Feb 2014
Q1 2012 $1.24B 01 Jan 2012 31 Mar 2012 10-K 21 Feb 2014

ABBOTT LABORATORIES Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $13.4B +$7.68B +134% 01 Jan 2024 31 Dec 2024 10-K 21 Feb 2025
2023 $5.72B -$1.21B -17.5% 01 Jan 2023 31 Dec 2023 10-K 21 Feb 2025
2022 $6.93B -$138M -1.95% 01 Jan 2022 31 Dec 2022 10-K 21 Feb 2025
2021 $7.07B +$2.58B +57.3% 01 Jan 2021 31 Dec 2021 10-K 16 Feb 2024
2020 $4.5B +$808M +21.9% 01 Jan 2020 31 Dec 2020 10-K 17 Feb 2023
2019 $3.69B +$1.32B +55.7% 01 Jan 2019 31 Dec 2019 10-K 18 Feb 2022
2018 $2.37B +$1.89B +396% 01 Jan 2018 31 Dec 2018 10-K 19 Feb 2021
2017 $477M -$923M -65.9% 01 Jan 2017 31 Dec 2017 10-K 21 Feb 2020
2016 $1.4B -$3.02B -68.3% 01 Jan 2016 31 Dec 2016 10-K 22 Feb 2019
2015 $4.42B +$2.14B +93.7% 01 Jan 2015 31 Dec 2015 10-K 16 Feb 2018
2014 $2.28B -$292M -11.3% 01 Jan 2014 31 Dec 2014 10-K 17 Feb 2017
2013 $2.58B -$3.39B -56.8% 01 Jan 2013 31 Dec 2013 10-K 19 Feb 2016
2012 $5.96B +$1.24B +26.1% 01 Jan 2012 31 Dec 2012 10-K 27 Feb 2015
2011 $4.73B 01 Jan 2011 31 Dec 2011 10-K 21 Feb 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.